|
Executive Directors:
CAI Dongchen, Chairman
Appointed as an executive director of the Company in 1998. Mr. Cai graduated from Hebei Pharmaceutical Finance College in the PRC and has over thirty years of technical and management experience in the pharmaceutical industry.
FENG Zhenying
Appointed as an executive director of the Company in 2003. Mr. Feng graduated from Hebei Chemical College in the PRC and has over twenty years of technical and management experience in the pharmaceutical industry.
CHAK Kin Man
Appointed as an executive director of the Company in 2005. Mr. Chak is a certified public accountant of the Hong Kong Institute of Certified Public Accountants and a fellow member of the Association of Chartered Certified Accountants. He holds a Bachelor of Social Sciences degree from the University of Hong Kong and has over 16 years of experience in auditing and financial management.
PAN Weidong
Appointed as an executive director of the Company in 2006. Mr. Pan graduated from Shijiazhuang Post College in the PRC and has more than 15 years of experience in financial management and accounting.
ZHAO John Huan
Appointed as an executive director of the Company in 2008. Mr. Zhao holds an MBA degree from Kellogg School of Management at Northwestern University, dual master's degrees in electric engineering and physics from Northern Illinois University and a bachelor's degree in physics from Nanijing Unversity. Mr. Zhao has extensive experience in senior management positions at several US and PRC companies. Mr. Zhao is also a vice president of Legend Holdings Limited, a director of Massive Giant Group Limited and the CEO of Hony Capital Limited.
WANG Shunlong
Appointed as an executive director of the Company in 2008. Mr. Wang holds a doctorate degree in engineering from Tsinghua University and has spent three years as a visiting researcher at Eindhoven University of Technology in the Netherlands. Mr. Wang has extensive experience in corporate management and investment planning. Mr. Wang is also a managing director of Hony Capital Limited and a director of Massive Giant Group Limited.
WANG Huaiyu
Appointed as an executive director of the Company in 2010. Mr. Wang holds a bachelor degree in microbiology and biochemistry from Hebei University and has more than 20 years of technical and management experience in the pharmaceutical industry.
LU Jianmin
Appointed as an executive director of the Company in 2010. Mr. Lu has more than 20 years of technical and management experience in the pharmaceutical industry.
WANG Zhenguo
Appointed as an executive director of the Comapny in 2012. Mr. Wang holds a bachelor degree in chemistry from Nankai University in the PRC and has more than 20 years of technical and management experience in the pharmaceuticl industry.
Non-executive Director:
LEE Ka Sze, Carmelo
Appointed as an independent non-executive director of the Company in 1996 and redesignated as a non-executive director in 2004. Mr. Lee holds a Bachelor of Laws degree from University of Hong Kong. He is a solicitor by profession and is a partner of a law firm in Hong Kong.
Independent non-executive Directors:
HUO Zhenxing
Appointed as an independent non-executive director of the Company in 1994. Mr. Huo was the former head of Industrial and Commercial Bank of China, Hebei Province branch and Shijiazhuang sub-branch.
QI Moujia
Appointed as an independent non-executive director of the Company in 1996. Mr. Qi was the former director of the State Food and Drug Administration of China ("SFDA"). He was the deputy chairman and chairman of SFDA in 1978 and 1982-1994 respectively.
GUO Shichang
Appointed as an independent non-executive director of the Company in 2004. Mr. Guo was the Vice Governor of Hebei Provincial People's Government, the PRC from 1993 to 2002.
CHAN Siu Keung, Leonard
Appointed as an independent non-executive director of the Company in 2004. Mr. Chan is a qualified accountant and a member of the Institute of Chartered Accountants of Ontario. Mr. Chan holds a Master of Business Administration degree from York University, Ontario, Canada and has extensive experience in finance and investment.
WANG Bo
Appointed as an independent non-executive director of the Company in 2012. Mr. Wang is currently the CEO of Beijing CHNMED Pharmaceutical Technology Development Co., Ltd and managing director of Beijing CHNMED Pharmaceutical Consulting Co., Ltd.. Mr. Wang is also currently an independent non-executive director of Winteam Pharmaceutical Group Ltd. (listed on The Stock Exchange of Hong Kong Limited), independent director of Jiangsu Wuzhong Industrial Co., Ltd. (listed on Shanghai Stock Exchange), Hainan Shuangcheng Pharmaceutical Co., Ltd. (listed on Shenzhen Stock Exchange), Guangxi Liuzhou Pharmaceutical Co., Ltd. and Mudanjiang Youbo Pharmaceutical Co. Ltd.. In addition, he was formerly an independent director of China Resources Double-crane Pharmaceutical Co., Ltd (listed on Shanghai Stock Exchange). Mr. Wang graduated from Beijing Institute of Iron and Steel and has extensive experience in pharmaceutical policy research and consulting. He is currently the vice-chairman of Chinese Pharmaceutical Enterprises Association and China National Association of Pharmaceutical and Medical Equipment Technical Market.
ZHANG Fawang
Appointed as an independent non-executive director of the Company in 2012. Mr. Zhang was formerly the vice-mayor of Shijiazhuang City, Hebei Province. Mr. Zhang holds a bachelor degree in Chinese from Hebei University.
|
